1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
658430B250FDC4F40852574AA00629527
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-benchmarking-pharmaceutical-chemistry-manufacturing-control-operations-resources-investments-and-activities?opendocument
18
19opendocument
2054.90.204.233
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Business Operations Manufacturing

Benchmarking Pharmaceutical Chemistry, Manufacturing and Control (CMC) Operations: Resources, Investments and Activities

ID: 5009


Features:

80 Data Graphics

200+ Metrics


Pages/Slides: 114


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • SPECIAL OFFER
Best Practices, LLC conducted this study to better understand resource and investment levels, expertise, and activities in global (pre-launch) Chemistry, Manufacturing and Control (CMC) operations in top pharmaceutical companies. This data-rich study provides numerous operational benchmarks around CMC facilities in terms of number/geographic locations, types of CMC activity performed, and FTEs by function and advanced degrees. The research also delivers benchmarks around number of projects, batches processed and timeframes for CMC activities. Other topic areas include capabilities & expertise and performance & measures. This study is intended to provide executives with data to assess the effectiveness and efficiency of their CMC operations and provide insights to improve drug development programs.


Data for this study is presented in two segments: A Total Benchmark Class containing all participants and a Top 30 segment, containing companies that are among the Top 30 by revenue.


Industries Profiled:
Pharmaceutical; Health Care; Medical Device; Biotech; Consumer Products


Companies Profiled:
Johnson & Johnson; Daiichi Sankyo; Pfizer; Gilead Sciences; GlaxoSmithKline; Novartis; Sanofi-aventis; Merck; Abbott Laboratories; Boehringer Ingelheim; Baxter Healthcare; Takeda Pharmaceuticals; Astellas; Eisai; Alcon Laboratories; Solvay Pharmaceuticals; Biogen Idec; Bausch & Lomb


Study Snapshot

This research was conducted on behalf of one of Best Practices, LLC's clients and was based on survey results from 18 participants from 18 companies. The participants represent a look at how Top Pharma Companies staff, structure, utilize and measure their CMC functions.

Key topics include:
  • Scope of Operations
  • Activities
  • Facilities
  • Resources and Education Levels
  • Outputs and Development Timeframes
  • Capabilities
  • Performance and Measures
  • Efficiency Ratios
  • Lessons Learned

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.